The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.
Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, Bugatti M, Salvi V, Bernardini G, Benvenuti F, Vecchi A, Bottazzi B, Mantovani A, Sozzani S.
Del Prete A, et al. Among authors: benvenuti f.
Cancer Immunol Res. 2019 Nov;7(11):1775-1788. doi: 10.1158/2326-6066.CIR-19-0168. Epub 2019 Sep 4.
Cancer Immunol Res. 2019.
PMID: 31484658
Free PMC article.